These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 17241118)

  • 1. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.
    Kim K; Moore DH; Makriyannis A; Abood ME
    Eur J Pharmacol; 2006 Aug; 542(1-3):100-5. PubMed ID: 16781706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders.
    Espejo-Porras F; Piscitelli F; Verde R; Ramos JA; Di Marzo V; de Lago E; Fernández-Ruiz J
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):233-44. PubMed ID: 25819934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glial cannabinoid CB
    Espejo-Porras F; García-Toscano L; Rodríguez-Cueto C; Santos-García I; de Lago E; Fernandez-Ruiz J
    Br J Pharmacol; 2019 May; 176(10):1585-1600. PubMed ID: 29574689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1
    Rodríguez-Cueto C; Santos-García I; García-Toscano L; Espejo-Porras F; Bellido M; Fernández-Ruiz J; Muñoz E; de Lago E
    Biochem Pharmacol; 2018 Nov; 157():217-226. PubMed ID: 30076846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
    J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.
    Witting A; Weydt P; Hong S; Kliot M; Moller T; Stella N
    J Neurochem; 2004 Jun; 89(6):1555-7. PubMed ID: 15189359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
    Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
    Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
    Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X; Peng Y; Liu M; Cui L
    Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
    Pryce G; Baker D
    Handb Exp Pharmacol; 2015; 231():213-31. PubMed ID: 26408162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
    Moreno-Martet M; Espejo-Porras F; Fernández-Ruiz J; de Lago E
    CNS Neurosci Ther; 2014 Sep; 20(9):809-15. PubMed ID: 24703394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the CB
    Rodríguez-Cueto C; Gómez-Almería M; García Toscano L; Romero J; Hillard CJ; de Lago E; Fernández-Ruiz J
    Brain Pathol; 2021 Nov; 31(6):e12972. PubMed ID: 33983653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.